Browse by Divisions pre August 2011

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
[tool] Add To Shelf...
Number of items: 149.

Ashcroft, Richard, Lucassen, Anneke, Parker, Michael and Widdershoven, Guy (eds.) (2005) Case analysis in clinical ethics, Cambridge, GB, Cambridge University Press, 262pp.

Alharbi, Khalid K., Aldahmesh, Mohammed A., Spanakis, Emmanuel, Haddad, Lema, Whittall, Roslyn A., Chen, Xiao-he, Rassoulian, Hamid, Smith, Matt J., Sillibourne, Julie, Ball, Nicola J., Graham, Nikki J., Briggs, Patricia J., Simpson, Iain A., Phillips, David I.W., Lawlor, Deborah A., Ye, Shu, Humphries, Stephen E., Cooper, Cyrus, Smith, George Davey, Ebrahim, Shah, Eccles, Diana M. and Day, Ian N.M. (2005) Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population. Genome Research, 15, (7), 967-977. (doi:10.1101/gr.3313405).

Antoniou, A.C., Pharoah, P.D., Narod, S., Risch, H.A., Eyfjord, J.E., Hopper, J.L., Olsson, H., Johannsson, O., Borg, A., Pasini, B., Radice, P., Manoukian, S., Eccles, D.M., Tang, N., Olah, E., Nton-Culver, H., Warner, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjakoski, K., Kallioniemi, O.P., Thompson, D., Evans, C., Peto, J., Lalloo, F., Evans, D.G. and Easton, D.F. (2005) Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. Journal of Medical Genetics, 42, (7), 602-603. (doi:10.1136/jmg.2004.024133).

Awasthi, Shally, Beardmore, Jil, Clark, Jocalyn, Hadridge, Philip, Madani, Hardi, Marusic, Ana, Purcell, Gretchen, Rhoads, Margaret, Sliwa-Hähnle, Karen, Smith, Richard, Edejer, Tessa Tan-Torres, Tugwell, Peter and Underwood, Tim (2005) Five futures for academic medicine. PLoS Medicine, 2, (7), e207-[8pp]. (doi:10.1371/journal.pmed.0020207).

Badami, Ester, Maiuri, Luigi and Quaratino, Sonia (2005) High incidence of spontaneous autoimmune thyroiditis in immunocompetent self-reactive human T cell receptor transgenic mice. Journal of autoimmunity, 24, (2), 85-91. (doi:10.1016/j.jaut.2005.01.003).

Barnes, J.D., Arhel, N.J., Lee, S.S., Sharp, A., Al-Okail, M., Packham, G., Hague, A., Paraskeva, C. and Williams, A.C. (2005) Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis, 10, (2), 301-311. (doi:10.1007/s10495-005-0804-8).

Beysen, D., Raes, J., Leroy, B. P., Lucassen, A., Yates, J. R., Clayton-Smith, J., Ilyina, H., Brooks, S. S., Christin-Maitre, S., Fellous, M., Fryns, J. P., Kim, J. R., Lapunzina, P., Lemyre, E., Meire, F., Messiaen, L. M., Oley, C., Splitt, M., Thomson, J., Peer, Y. V., Veitia, R. A., De Paepe, A. and De Baere, E. (2005) Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. American Journal of Human Genetics, 77, (2), 205-218. (doi:10.1086/432083).

Bowen, D.T., Frew, M.E., Hills, R., Gale, R.E., Wheatley, K., Groves, M.J., Langabeer, S.E., Kottaridis, P.D., Moorman, A.V., Burnett, A.K. and Linch, D.C. (2005) RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. Blood, 106, (6), 2113-2119. (doi:10.1182/blood-2005-03-0867).

Buchan, Sarah, Gronevik, Eirik, Mathiesen, Iacob, King, Catherine A., Stevenson, Freda K. and Rice, Jason (2005) Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen. Journal of Immunology, 174, (10), 6292-6298.

Campbell, I.G., Eccles, D.M. and Choong, D.Y. (2005) No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer. Cancer Letters, 17

Cathomas, R., Pelosi, E., Smart, J., Murray, N. and Simmonds, P. (2005) Herpes simplex encephalitis as a complication of adjuvant chemotherapy treatment for breast cancer. Clinical oncology, 17, (4), 292-293. (doi:10.1016/j.clon.2004.07.016).

Chanalaris, Anastasios, Lawrence, Kevin M., Townsend, Paul A., Davidson, Sean, Jamshidi, Yalada, Stephanou, Anastasis, Knight, Richard D., Hsu, Sheau Y., Hsueh, Aaron J.W. and Latchman, David S. (2005) Hypertrophic effects of urocortin homologous peptides are mediated via activation of the Akt pathway. Biochemical and Biophysical Research Communications, 328, (2), 442-448. (doi:10.1016/j.bbrc.2005.01.001).

Chandran, S., Parvaiz, A., Karim, A., Ghafoor, I., Steadman, B., Pearce, N.W. and Primrose, J.N. (2005) Ruptured left gastric artery aneurysm successfully treated by thrombin injection: case report and literature review. The Scientific World Journal, 5, 20-23. (doi:10.1100/tsw.2005.8).

Chau, I., Norman, A.R., Cunningham, D., Tait, D., Ross, P.J., Iveson, T., Hill, M., Hickish, T., Lofts, F., Jodrell, D., Webb, A. and Oates, J.R. (2005) A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Annals of oncology, 16, (4), 549-557. (doi:10.1093/annonc/mdi116).

Chau, Ian, Norman, Andrew R., Cunningham, David, Iveson, Tim, Hill, Mark, Hickish, Tamas, Lofts, Fiona, Jodrell, Duncan, Webb, Andrew, Tait, Diana, Ross, Paul J., Shellito, Pat and Oates, Jacqueline R. (2005) Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer. European Journal of Cancer, 41, (11), 1551-1559. (doi:10.1016/j.ejca.2005.01.027).

Chiecchio, Laura, Protheroe, Rebecca K.M., Parker, Tim, Rudduck, Christina, Cheung, Kan Luk, Dagrada, Gianpaolo, Wechalekar, Ashutosh, Nightingale, Mathew, Harrison, Christine J., Cross, Nicholas C.P. and Ross, Fiona M. (2005) Critical importance of conventional cytogenetics in detecting prognostically significant chromosome 13 deletions in myeloma. Blood, 106, (11), p.443A.

Chu, Q., Rowinsky, E., Goldstein, L., Cianfrocca, M., Murray, N., Gale, M., Ho, P.T., Loftiss, J.I., Paul, E. and Pandite, L. (2005) Phase I study of lapatinib (GW572016) in combination with letrozole in cancer patients. EJC Supplements, 3, (2), 119-119.

Clarke, Angus, Richards, Martin, Kerzin-Storrar, Lauren, Halliday, Jane, Young, Mary Anne, Simpson, Sheila A., Featherstone, Katie, Forrest, Karen, Lucassen, Anneke, Morrison, Patrick J., Quarrell, Oliver W.J. and Stewart, Helen (2005) Genetic professionals' reports of nondisclosure of genetic risk information within families. European Journal of Human Genetics, 13, (5), 556-562. (doi:10.1038/sj.ejhg.5201394).

Clemo, N.K., Arhel, N.J., Barnes, J.D., Baker, J., Moorghen, M., Packham, G.K., Paraskeva, C. and Williams, A.C. (2005) The role of the retinoblastoma protein (Rb) in the nuclear localization of BAG-1: implications for colorectal tumour cell survival. Biochemical Society Transactions, 33, 676-678.

Coenen, S., Pickering, B., Potter, K.N., Johnson, P.W., Stevenson, F.K. and Packham, G. (2005) The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells. Haematologica, 90, (9), 1285-1286.

Copson, Ellen R. (2005) Non-Hodgkin's lymphoma (diffuse large B cell lymphoma). Clinical Evidence, (13), 1-18.

Cragg, M.S., Walshe, C.A., Ivanov, A.O. and Glennie, M.J. (2005) The biology of CD20 and its potential as a target for mAb therapy. Current directions in autoimmunity, 8, 140-174. (doi:10.1159/000082102).

Cullen, Michael, Steven, Neil, Billingham, Lucinda, Gaunt, Claire, Hastings, Mark, Simmonds, Peter, Stuart, Nicholas, Rea, Daniel, Bower, Mark, Fernando, Indrajit, Huddart, Robert, Gollins, Simon and Stanley, Andrew, for the Simple Investigation in Neutropenic Individuals (2005) Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. New England Journal of Medicine, 353, (10), 988-998. (doi:10.1056/NEJMoa050078).

Dallman, Claire and Packham, Graham (2005) Purification of primary malignant B-cells and immunoblot analysis of bcl-2 family proteins. In, Lymphoma: methods and protocols. , Humana Press, 1-14. (Methods in Molecular Medicine, 115).

Danson, S., Johnson, P., Ward, T., Dawson, M., Denneny, O., Cummings, J., Jowle, D., Howard, E., Dive, C. and Ranson, M. (2005) Phase I pharmacokinetic (PK) and pharmacodynamic (PD) trial of the bioreductive drug RH140. Clinical Cancer Research, 11, (24), p.9150S.

Darby, A.J., Lanham, S., Soubeyran, P. and Johnson, P.W. (2005) Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study. Haematologica, 90, (12), 1706-1707.

Davies, A.J. (2005) A review of tositumomab and I(131) tositumomab radioimmunotherapy for the treatment of follicular lymphoma. Expert Opinion on Biological Therapy, 5, (4), 577-588. (doi:10.1517/14712598.5.4.577).

Davies, A.J., Lee, A.M., Taylor, C., Clear, A.J., Goff, L.K., Iqbal, S., Cuthbert-Heavens, D., Calaminici, M., Norton, A.J., Lister, T.A. and Fitzgibbon, J. (2005) A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia, 19, (8), 1459-1465. (doi:10.1038/sj.leu.2403802).

Davies, Andrew J. and Gribben, John G. (2005) Hematopoietic stem cell transplantation in non-Hodgkin lymphoma. Current Opinion In Organ Transplantation, 10, (1), 35-39.

Day, Ian N.M., Aldahmesh, Mohammed A., Haddad, Lema, Alharbi, Khalid K., Chen, Xiao-he, Rassoulian, Hamid, Humphries, Steve E., Spanakis, Emmanuel and Eccles, Diana, Human Genome Organization (HUGO) (2005) MeltMADGE: economical very high-throughput mutation scanning using thermal ramp electrophoresis in conjunction with MADGE (microplate array) gels. In, Taylor, Graham R. and Day, Ian N. (eds.) Guide to Mutation Detection. Hoboken, USA, Wiley, 85-99.

Delaney, R.J., Sayers, C.D., Walker, M.A., Mead, G.M. and Theaker, J.M. (2005) The continued value of central histopathological review of testicular tumours. Histopathology, 47, (2), 166-169. (doi:10.1111/j.1365-2559.2005.02207.x).

Drukier, A.K., Ossetrova, N., Schors, E., Brown, L.R., Tomaszewski, J., Sainsbury, R. and Godovac-Zimmermann, J. (2005) Ultra-sensitive immunoassays using multi-photon-detection in diagnostic proteomics of blood. Journal of Proteome Research, 4, (6), 2375-2378. (doi:10.1021/pr050320n).

Drukier, A.K., Ossetrova, N., Schors, E., Brown, L.R., Tomaszewski, J., Sainsbury, R. and Godovac-Zimmermann, J. (2005) Ultra-sensitive immunoassays using multi-photon-detection in diagnostic proteomics of blood. Journal of Proteome Research, 4, (6), 2375-2378. (doi:10.1021/pr050320n).

Dyer, Martin J.S., Akasaka, Takashi, Balasas, Theodore, Russell, Lisa, Sugimoto, Kei-Ji, Majid, Aneela, Brown, David G., Cain, Kelvin, Strefford, Jon C., Harrison, Christine J. and Siebert, Reiner (2005) Involvement of the CEBP gene family in four IGH@ chromosomal translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood, 106, (11), p.797A.

Eccles, D., Bunyan, D., Barker, S. and Castle, B. (2005) BRCA1 mutation and neuronal migration defect: Implications for chemoprevention. Journal of Medical Genetics, 42, (e24) (doi:10.1136/jmg.2004.028084).

Eccles, D.M. and Pichert, G. (2005) Familial non-BRCA1/BRCA2-associated breast cancer. The lancet oncology, 6, (9), 705-711. (doi:10.1016/S1470-2045(05)70318-1).

Elliott, T. and Williams, A. (2005) The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunological Reviews, 207, 89-99. (doi:10.1111/j.0105-2896.2005.00311.x).

Erenpreisa, J., Kalejs, M. and Cragg, M. S. (2005) Mitotic catastrophe and endomitosis in tumour cells: An evolutionary key to a molecular solution. Cell Biology International, 29, (12), 1012-1018. (doi:10.1016/j.cellbi.2005.10.005).

Erenpreisa, J., Kalejs, M., Ianzini, F., Kosmacek, E.A., Mackey, M.A., Emzinsh, D., Cragg, M.S., Ivanov, A. and Illidge, T.M. (2005) Segregation of genomes in polyploid tumour cells following mitotic catastrophe. Cell biology international, 29, (12), 1005-1011. (doi:10.1016/j.cellbi.2005.10.008).

Fischer, D.S., Allan, G.M., Bubert, C., Vicker, N., Smith, A., Tutill, H.J., Purohit, A., Wood, L., Packham, G., Mahon, M.F., Reed, M.J. and Potter, B.V. (2005) E-ring modified steroids as novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1. Journal of Medicinal Chemistry, 48, (18), 5749-5770. (doi:10.1021/jm050348a).

Fisher, A.M., Strike, P., Scott, C. and Moorman, A.V. (2005) Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome. Genes, chromosomes and cancer, 43, (4), 383-389. (doi:10.1002/gcc.20196).

Fitzsimmons, Deborah, Hawker, Sheila E., Simmonds, Peter, George, Steve L., Johnson, Colin D. and Corner, Jessica L. (2005) Nurse-led models of chemotherapy care: mixed economy or nurse–doctor substitution? Journal of Advanced Nursing, 50, (3), 244-252. (doi:10.1111/j.1365-2648.2005.03387.x).

Fitzsimmons, Deborah, Kahl, Stefan, Butturini, Giovanni, Van Wyk, Marc, Bornman, Phillipus, Bassi, Claudio, Malfertheiner, Peter, George, Steve L. and Johnson, Colin D. (2005) Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. American Journal of Gastroenterology, 100, (4), 918-926. (doi:10.1111/j.1572-0241.2005.40859.x).

Gennery, Andrew R., Hodges, Elizabeth, Williams, Anthony P., Harris, Susan, Villa, Anna, Angus, Brian, Cant, Andrew J. and Smith, John L. (2005) Omenn's syndrome occurring in patients without mutations in recombination activating genes. Clinical Immunology, 116, (3), 246-256. (doi:10.1016/j.clim.2005.04.014).

Gibson, B.E., Wheatley, K., Hann, I.M., Stevens, R.F., Webb, D., Hills, R.K., De Graaf, S.S. and Harrison, C.J. (2005) Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia, 19, (12), 2130-2138. (doi:10.1038/sj.leu.2403924).

Gidron, Yori, Perry, Hugh and Glennie, Martin (2005) Does the vagus nerve inform the brain about preclinical tumours and modulate them? Lancet Oncology, 6, (4), 245-248. (doi:10.1016/S1470-2045(05)70096-6). (PMID:15811620).

Guinn, Barbar-ann, Bland, Elizabeth A., Lodi, Usman, Liggins, Amanda P., Tobal, Khalid, Petters, Sarah, Wells, James W., Banham, Alison H. and Mufti, Ghulam J. (2005) Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia. Biochemical and Biophysical Research Communications, 335, (4), 1293-1304. (doi:10.1016/j.bbrc.2005.08.024).

Guinn, Barbara-ann, Gilkes, Amanda F., Woodward, Eleanor, Westwood, Nigel B., Mufti, Ghulam J., Linch, David, Burnett, Alan K. and Mills, Ken I. (2005) Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia. Biochemical and Biophysical Research Communications, 333, (3), 703-713. (doi:10.1016/j.bbrc.2005.05.161).

Gunter, Marc J., Watson, Mark A., Loktionov, Alexandre S., Mitrou, Panagiota, Cecil, Tom, Macklin, Christopher, Cardwell, Christopher, Bishop, D. Timothy, Primrose, John, Atkin, Wendy S. and Bingham, Sheila A. (2005) No association between cytochrome P450 and glutathione S-transferase gene polymorphisms and risk of colorectal adenoma: results from the UK Flexible Sigmoidoscopy Screening Trial. Cancer Epidemiology, Biomarkers & Prevention, 14, (4), 1028-1030.

Habens, F., Srinivasan, N., Oakley, F., Mann, D.A., Ganesan, A. and Packham, G. (2005) Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity. Apoptosis, 10, (3), 481-491. (doi:10.1007/s10495-005-1877-0).

Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C. and Watson, M. (2005) Men's decision-making about predictive BRCA1/2 testing: the role of family. Journal of Genetic Counseling, 14, (3), 207-217. (doi:10.1007/s10897-005-0384-3).

Hamblin, Angela D. and Hamblin, Terry J. (2005) Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemia. Expert Opinion on Therapeutic Targets, 9, (6), 1165-1178. (doi:10.1517/14728222.9.6.1165).

Hamblin, Terry J. (2005) The management of anemia in the myelodysplastic syndrome. Leukemia Research, 29, (10), 1101-1102. (doi:10.1016/j.leukres.2005.03.009).

Hamblin, Terry J. (2005) Richter's syndrome--the downside of fludarabine? Leukemia Research, 29, (10), 1103-1104. (doi:10.1016/j.leukres.2005.02.020).

Harper-Wynne, C.L., Sumpter, K., Ryan, C., Priest, K., Norton, A., Ross, P., Ford, H.E.R., Johnson, P. and O'Brien, M.E.R. (2005) Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control. Lung Cancer, 47, (2), 289-290. (doi:10.1016/j.lungcan.2004.08.013).

Harrison, C. (2005) Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization. Haematologica, 90, (6), 721.

Harrison, C.J. (2005) Detection of genomic aberrations in older patients with acute myeloid leukemia. Haematologica, 90, (2), 147.

Harrison, Christine J., Moorman, Anthony V., Barber, Kerry E., Broadfield, Zoë J., Cheung, Kan L., Harris, Rachel, Jalali, G. Reza, Robinson, Hazel M., Strefford, Jonathan C., Stewart, Adam, Wright, Sarah, Griffiths, Mike, Ross, Fiona M., Harewood, Louise and Martineau, Mary (2005) Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. British Journal of Haematology, 129, (4), 520-530. (doi:10.1111/j.1365-2141.2005.05497.x).

Hearle, Nicholas C.M., Tomlinson, Ian, Lim, Wendy, Murday, Victoria, Swarbrick, Edwin, Lim, Guan, Phillips, Robin, Lee, Peter, O'Donohue, John, Trembath, Richard C., Morrison, Patrick J., Norman, Andrew, Taylor, Rohan, Hodgson, Shirley, Lucassen, Anneke and Houlston, Richard S. (2005) Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndrome. BMC Genomics, 6, (38) (doi:10.1186/1471-2164-6-38).

Honeychurch, Jamie, Glennie, Martin J. and Illidge, Timothy M. (2005) Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells. Cancer Research, 65, (16), 7493-7501. (doi:10.1158/0008-5472.CAN-04-3808).

Howell, W.M., Pead, P.J., Shek, F.W., Rose-Zerilli, M.J., Armstrong, T., Johnson, C.D., Fine, D.R., Iredale, J.P. and Bateman, A.C. (2005) Influence of cytokine and ICAM-1 gene polymorphisms on susceptibility to chronic pancreatitis. Journal of Clinical Pathology, 58, (6), 595-599. (doi:10.1136/jcp.2004.020842).

Huddart, R., O'Doherty, M., Padhani, A., Rustin, G., Mead, G., Seiby, P., Vasey, P., Wow, M., Kirk, S. and Stenning, S. (2005) A prospective study of 18FDG PET in the prediction of relapse in patients with high risk clinical stage I (CS1) non-seminomatous germ cell cancer (NSGCT): MRC study TE22. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 24, (18S), 4520.

Jardin, Fabrice and Sahota, Surinder S. (2005) Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis. Hematology, 10, (2), 115-129. (doi:10.1080/10245330400026105).

Johnson, C.D. (2005) Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut, 54, v1-v16. (doi:10.1136/gut.2004.057059).

Johnson, C.D., Charnley, R.B., Carter, R., Bassi, C., Chalmers, A., Imrie, C.W., Larvin, M., Mitchell, C.J., Neoptolemos, J.M., Siriwardena, A., Aly, E., Butturini, G. and Kelly, J. (2005) UK guidelines for the management of acute pancreatitis. Gut, 54, (5), iii1-iii9. (doi:10.1136/gut.2004.057026).

Johnson, P.W.M., Radford, J.A., Cullen, M.H., Sydes, M.R., Walewski, J., Jack, A.S., MacLennan, K.A., Stenning, S.P., Clawson, S., Smith, P., Ryder, D. and Hancock, B.W. (2005) Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). Journal of Clinical Oncology, 23, (36), 9208-9218. (doi:10.1200/JCO.2005.03.2151).

Johnson, Peter, Geldart, Thomas, Fumoleau, Pierre, Pinel, Marie-Claire, Nguyen, Laurent and Judson, Ian (2005) Phase I study of Vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks. Investigational new drugs, 24, (3), 223-231. (doi:10.1007/s10637-005-3902-0).

Jones, William G., Fossa, Sophie D., Mead, Graham M., Roberts, J. Trevor, Sokal, Michael, Horwich, Alan and Stenning, Sally P. (2005) Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). Journal of Clinical Oncology, 23, (6), 1200-1208. (doi:10.1200/JCO.2005.08.003).

Khalili-Shirazi, A., Quaratino, S., Londei, M., Summers, L., Tayebi, M., Clarke, A.R., Hawke, S.H., Jackson, G.S. and Collinge, J. (2005) Protein conformation significantly influences immune responses to prion protein. Journal of Immunology, 174, (6), 3256-3263.

Konduri, K., Sahota, S.S., Babbage, G., Tong, A.W., Kumar, P., Newman, J.T. and Stone, M.J. (2005) Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression. Clinical Lymphoma, 5, (4), 285-289.

Krishna, Mamidipudi T., Goswami, Rajee, Frew, Anthony J., Smith, John L. and Williams, Anthony P. (2005) Laboratory diagnostics for hereditary angioedema: An economic, evidence-based standpoint. The Journal of Allergy and Clinical Immunology, 115, (4), 878-879. (doi:10.1016/j.jaci.2004.12.1126).

Kwon, Young Jik, James, Edward, Shastri, Nilabh and Fréchet, Jean M.J. (2005) In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proceedings of the National Academy of Sciences of the United States of America, 102, (51), 18264-18268. (doi:10.1073/pnas.0509541102).

Lawrence, Kevin M., Kabir, Alamgir M.N., Bellahcene, Mohammed, Davidson, Sean, Mesquita, Rue S., Cao, Xuebin, McCormick, James, Carroll, Christopher J., Chanalaris, Anastasios, Townsend, Paul A., Hubank, Mike, Stephanou, Anastasis, Knight, Richard A., Marber, Michael S. and Latchman, David S. (2005) Cardioprotection mediated by urocortin is dependent on PKCepsilon activation. The FASEB Journal, 19, (7), 831-833. (doi:10.1096/fj.04-2506fje).

Leach, M.O., Boggis, C.R., Dixon, A.K., Easton, D.F., Eeles, R.A., Evans, D.G., Gilbert, F.J., Griebsch, I., Hoff, R.J., Kessar, P., Lakhani, S.R., Moss, S.M., Nerurkar, A., Padhani, A.R., Pointon, L.J., Thompson, D., Warren, R.M. and MARIBS, study group (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet, 365, (9473), 1769-1778. (doi:10.1016/S0140-6736(05)66481-1).

Liggins, A., Guinn, B.A. and Banham, A.H. (2005) Identification of lymphoma-association antigens using SEREX. In, Illidge, Tim and Johnson, Peter W.M. (eds.) Lymphoma. UK, Springer, 109-128. (Methods in Molecular Medicine, 115).

Londei, M., Ciacci, C., Ricciardelli, I., Vacca, L., Quaratino, S. and Maiuri, L. (2005) Gliadin as a stimulator of innate responses in celiac disease. Molecular Immunology, 42, (8), 913-918. (doi:10.1016/j.molimm.2004.12.005).

Londei, Marco, Maiuri, Luigi and Quaratino, Sonia (2005) A search for the holy grail: non-toxic gluten for celiac patients. Gastroenterology, 129, (3), 1111-1113.

Lucassen, A. and Watson, E. (2005) Family history of breast cancer. British Medical Journal, 330, (7481) (doi:10.1136/bmj.330.7481.26).

Lucassen, Anneke (2005) Response to ethical dissections of the case. In, Ashcroft, Richard, Lucassen, Anneke, Parker, Michael, Verkerk, Marian and Widdershoven, Guy (eds.) Case Analysis in Clinical Ethics. Cambridge, GB, Cambridge University Press, 213-224.

Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Raia, V., Rispo, A., Griffin, M., Issekutz, T., Quaratino, S. and Londei, M. (2005) Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology, 129, (5), 1400-1413. (doi:10.1053/j.gastro.2005.07.054).

Mann, Jelena, Patrick, Claire N., Cragg, Mark S., Honeychurch, Jamie, Mann, Derek A. and Harris, Mark (2005) Functional analysis of HIV type 1 Nef reveals a role for PAK2 as a regulator of cell phenotype and function in the murine dendritic cell line, DC2.4. Journal of Immunology, 175, (10), 6560-6569.

Marks, A.J., Cooper, M.S., Anderson, R.J., Orchard, K.H., Hale, G., North, J.M., Ganeshaguru, K., Steele, A.J., Mehta, A.B., Lowdell, M.W. and Wickremasinghe, R.G. (2005) Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide. Cancer Research, 65, (6), 2373-2377.

Marks, Alexandra J., Cooper, Margaret S., Anderson, Robert J., Orchard, Kim H., Hale, Geoffrey, North, Janet M., Ganeshaguru, Kanagasabai, Steele, Andrew J., Mehta, Atul B., Lowdell, Mark W. and Wickremasinghe, R. Gitendra (2005) Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide. Cancer Research, 65, (6), 2373-2377. (doi:10.1158/0008-5472.CAN-04-2594 ). (PMID:15781652).

Martineau, Mary, Jalali, G. Reza, Barber, Kerry E., Broadfield, Zoë J., Cheung, Kan Luk, Lilleyman, John, Moorman, Anthony V., Richards, Sue, Robinson, Hazel M., Ross, Fiona and Harrison, Christine J. (2005) ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications. Genes, Chromosomes and Cancer, 43, (1), 54-71. (doi:10.1002/gcc.20158).

McCann, Katy, Sahota, Surinder S., Stevenson, Freda K. and Ottensmeier, Christian H. (2005) Idiotype gene rescue in follicular lymphoma. In, Lymphoma: methods and protocols. , Humana Press, 145-171. (Methods in Molecular Medicine, 115).

McFarlane, V., Friedmann, P.S. and Illidge, T.M. (2005) What's new in the management of cutaneous T-cell lymphoma. Clinical Oncology, 17, (3), 174-184. (doi:10.1016/j.clon.2004.11.010).

Mead, G. M., Cullen, M. H., Huddart, R., Harper, P., Rustin, G. J., Cook, P. A., Stenning, S. P. and Mason, M. (2005) A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. British Journal of Cancer, 93, (2), 178-184. (doi:10.1038/sj.bjc.6602682).

Michels, J., Foria, V., Packham, G., Mead, B. and Johnson, P. (2005) Expression of the anti-apoptotic MCL-1 is a marker of grade and prognosis in follicular lymphoma (FL). Annals of Oncology, 16, supplement 5, v106-v107. (doi:10.1093/annonc/mdi567).

Michels, Jorg, Johnson, Peter W.M. and Packham, Graham (2005) Mcl-1. The International Journal of Biochemistry & Cell Biology, 37, (2), 267-271. (doi:10.1016/j.biocel.2004.04.007).

Mikkelsen, René, Mutenda, Kudzai E., Mant, Alexandra, Schürmann, Peter and Blennow, Andreas (2005) α-glucan, water dikinase (GWD): a plastidic enzyme with redox-regulated and coordinated catalytic activity and binding affinity. Proceedings of the National Academy of Sciences of the United States of America, 102, (5), 1785-1790. (doi:10.1073/pnas.0406674102).

Mimura, Yusuke, Golgher, Denise, Mimura-Kimura, Yuka, Dwek, Raymond A., Rudd, Pauline M. and Elliott, Tim (2005) Immunogenicity of calreticulin-bound murine leukemia virus glycoprotein gp90. Glycobiology and Medicine, 564, 85-94. (doi:10.1007/0-387-25515-X_13).

Mirmalek-Sani, Sayed-Hadi, Tare, Rahul S., Morgan, Suzanne M., Roach, Helmtrud I., Wilson, David I., Hanley, Neil A. and Oreffo, Richard O.C. (2005) Characterization and multipotentiality of human fetal femur-derived cells: implications for skeletal tissue regeneration. Stem Cells, 24, (4), 1042-1053. (doi:10.1634/stemcells.2005-0368).

Montillo, M., Hamblin, T., Hallek, M., Montserrat, E. and Morra, E. (2005) Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica, 90, (3), 391-399.

Moorman, A.V., Raimondi, S.C., Pui, C.H., Baruchel, A., Biondi, A., Carroll, A.J., Forestier, E., Gaynon, P.S., Harbott, J., Harms, D.O., Heerema, N., Pieters, R., Schrappe, M., Silverman, L.B., Vilmer, E. and Harrison, C.J. (2005) No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities. Leukemia, 19, (4), 557-563. (doi:10.1038/sj.leu.2403695).

Moorman, Anthony V., Harrison, Christine J., Richards, Sue M., Fielding, Adele, Tallman, Martin S., Litzow, Mark R., Rowe, Jacob M., Goldstone, Anthony H. and Dewald, Gordon W. (2005) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): analysis of cytogenetic data from 1,235 patients on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood, 106, (11), p.100A.

Nystrom, M.L., Thomas, G.J., Hart, I.R., Stone, M., Mackenzie, I.C. and Marshall, J.F. (2005) Development of a quantitative method to analyse tumour cell invasion in organotypic culture. Journal of Pathology, 205, (4), 468-475. (doi:10.1002/path.1716).

Oliver, R.T.D., Mason, M.D., Mead, G.M., von der Maase, H., Rustin, G.J.S., Joffe, J.K., de Wit, R., Aass, N., Graham, J.D., Coleman, R., Kirk, S.J. and Stenning, S.P. (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet, 366, (9482), 293-300. (doi:10.1016/S0140-6736(05)66984-X).

Ottensmeier, Christian H., McCann, Katy J., Johnson, Peter and Stevenoson, Freda K. (2005) Immunogenetic profiling of follicular lymphoma reveals universal N-glycosylation sites introduced into the B cell receptor by somatic mutation and suggests relevance to lymphoma pathogenesis. Blood, 106, (11), p.180A.

Packham, Graham and Stevenson, Freda K. (2005) Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology, 114, (4), 441-449. (doi:10.1111/j.1365-2567.2005.02117.x).

Peniket, Andrew, Wainscoat, James, Side, Lucy, Daly, Sarah, Kusec, Rajko, Buck, Georgina, Wheatley, Keith, Walker, Helen, Chatters, Steve, Harrison, Christine, Boultwood, Jacqueline, Goldstone, Anthony and Burnett, Alan (2005) Del (9q) AML: clinical and cytological characteristics and prognostic implications. British Journal of Haematology, 129, (2), 210-220. (doi:10.1111/j.1365-2141.2005.05445.x).

Perkins, Stuart D., Flick-Smith, Helen C., Garmory, Helen S., Essex-Lopresti, Angela E., Stevenson, Freda K. and Phillpotts, Robert J. (2005) Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax. Genetic Vaccines and Therapy, 3, (1) (doi:10.1186/1479-0556-3-3).

Perkins, Stuart D., Hartley, M. Gill, Lukaszewski, Roman A., Phillpotts, Robert J., Stevenson, Freda. K. and Bennett, Alice M. (2005) VP22 enhances antibody responses from DNA vaccines but not by intercellular spread. Vaccine, 23, (16), 1931-1940. (doi:10.1016/j.vaccine.2004.10.033).

Phelps, Monika, Phillips, Anna, Darley, Matthew and Blaydes, Jeremy P. (2005) MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm. The Journal of Biological Chemistry, 280, (17), 16651-16658. (doi:10.1074/jbc.M412334200).

Pickering, Becky M. and Willis, Anne E. (2005) The implications of structured 5' untranslated regions on translation and disease. Seminars in Cell and Developmental Biology, 16, (1), 39-47. (doi:10.1016/j.semcdb.2004.11.006).

Pop, Laurentiu M., Smallshaw, Joan E., Tucker, Thomas F., Stevenson, Freda K. and Vitetta, Ellen S. (2005) Failure of vaccination with idiotypic protein or DNA, (+/-IL-2), the depletion of regulatory T cells, or the blockade of CTLA-4 to prolong dormancy in mice with BCL1 lymphoma. Journal of Immunotherapy, 28, (6), 525-534.

Porakishvili, N., Kulikova, N., Jewell, A.P., Youinou, P.Y., Yong, K., Nathwani, A., Heelan, B., Duke, V., Hamblin, T.J., Wallace, P., Ely, P., Clark, E.A. and Lydyard, P.M. (2005) Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes. British journal of haematology, 131, (3), 313-319. (doi:10.1111/j.1365-2141.2005.05775.x).

Poston, Graeme J., Adam, René, Alberts, Steven, Curley, Steven, Figueras, Juan, Haller, Daniel, Kunstlinger, Francis, Mentha, Gilles, Nordlinger, Bernard, Patt, Yehuda, Primrose, John, Roh, Mark, Rougier, Philippe, Ruers, Theo, Schmoll, Hans Joachim, Valls, Carlos, Vauthey, Nick Jean-Nicolas, Cornelis, Marleen and Kahan, James P. (2005) OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. Journal of Clinical Oncology, 23, (28), 7125-7134. (doi:10.1200/JCO.2005.08.722).

Primrose, J.N. (2005) Approach to the treatment of primary liver cancer. The Medical journal of Malaysia, 60, (Supplement B), 104-107.

Primrose, J.N. (2005) Managing liver metastases: myth or reality? The Medical journal of Malaysia, 60, (Supplement B), 67-69.

Quaratino, S., Ruf, J., Osman, M., Guo, J., McLachlan, S., Rapoport, B. and Londei, M. (2005) Human autoantibodies modulate the T cell epitope repertoire but fail to unmask a pathogenic cryptic epitope. Journal of immunology, 174, (1), 557-563.

Rabinovich, S.S., Seledtsov, V.I., Banul, N.V., Poveshchenko, O.V., Senyukov, V.V., Astrakov, S.V., Samarin, D.M. and Taraban, V.Y. (2005) Cell therapy of brain stroke. Bulletin of experimental biology and medicine, 139, (1), 126-128. (doi:10.1007/s10517-005-0230-5).

Raia, V., Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Auricchio, S., Cimmino, M., Cavaliere, M., Nardone, M., Cesaro, A., Malcolm, J., Quaratino, S. and Londei, M. (2005) Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis. Thorax, 60, (9), 773-780. (doi:10.1136/thx.2005.042564).

Rew, D.A. (2005) Research databases and data sets in cancer surgery. European Journal of Surgical Oncology, 31, (2), 115-116. (doi:10.1016/j.ejso.2004.09.016).

Robinson, H.M., Martineau, M., Harris, R.L., Barber, K.E., Jalali, G.R., Moorman, A.V., Strefford, J.C., Broadfield, Z.J., Cheung, K.L. and Harrison, C.J. (2005) Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia. Leukemia, 19, (4), 564-571. (doi:10.1038/sj.leu.2403629).

Robinson, Hazel M., Harrison, Christine J., Selzer, Rebecca, van Delft, Frederik and Strefford, Jon C. (2005) A breakage-fusion-bridge cycle generated by telomeric loss may underlie the dup(21q) of acute lymphoblastic leukemia. Blood, 106, (11), p.797A.

Ross, Fiona M. and Harrison, Christine J. (2005) Karyotyping lymph node biopsies in non-Hodgkin's lymphoma. In, Illidge, Tim and Johnson, Peter W.M. (eds.) Lymphoma: methods and protocols. , Humana Press, 93-108. (Methods in Molecular Medicine, 115).

Roy, A., Cargill, A., Love, S., Moorman, A.V., Stoneham, S., Lim, A., Darbyshire, P.J., Lancaster, D., Hann, I., Eden, T. and Saha, V. (2005) Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial. British journal of haematology, 130, (1), 67-75. (doi:10.1111/j.1365-2141.2005.05572.x).

Roy, Anindita, Bradburn, Mike, Moorman, Anthony V., Burrett, Julie, Love, Sharon, Kinsey, Sally E., Mitchell, Chris, Vora, Ajay, Eden, Tim, Lilleyman, John S., Hann, Ian and Saha, Vaskar (2005) Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial. British Journal of Haematology, 129, (1), 35-44. (doi:10.1111/j.1365-2141.2005.05425.x).

Rudd, R.M., Gower, N.H., Spiro, S.G., Eisen, T.G., Harper, P.G., Littler, J.A.H., Hatton, M., Johnson, P.W.M., Martin, W.M.C., Rankin, E.M., James, L.E., Gregory, W.M., Qian, W. and Lee, S.M. (2005) Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology, 23, (1), 142-153. (doi:10.1200/JCO.2005.03.037).

Sahota, Surinder S., Babbage, Gavin, Townsend, Mark, Mockridge, Ian C., Zojer, Niklas, Garand, Richard, Shaughnessy, John and Stevenson, Freda K. (2005) IgM-expressing Waldenstrom's Macroglobulinemia tumor cells reveal a potential for isotype switch. Blood, 106, (11), p.292A.

Sahota, Surinder S., Babbage, Gavin, Zojer, Niklas, Ottensmeier, Christian H. and Stevenson, Freda K. (2005) Determining mutational status of immunoglobulin v genes in chronic lymphocytic leukemia: a useful prognostic indicator. In, Lymphoma: methods and protocols. , Humana Press, 129-144. (Methods in Molecular Medicine, 115).

Sahota, Surinder S., Townsend, Mark and Stevenson, Freda K. (2005) Identification and assembly of V genes as idiotype-specific DNA fusion vaccines in multiple myeloma. In, Multiple Myeloma: methods and protocols. , Humana Press, 105-120. (Methods in Molecular Medicine, 113).

Sahota , Surinder S., Babbage , Gavin, Garand, Richard, Zojer, Niklas and Stevenson , Freda (2005) Dynamics of activation induced cytidine deaminase expression in t(11;14) mantle cell lymphoma. Blood, 105, (7), 2997-2999.

Savelyeva, Natalia, King, Catherine A., Vitetta, Ellen S. and Stevenson, Freda K. (2005) Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help. Proceedings of the National Academy of Sciences of the United States of America, 102, (31), 10987-10992. (doi:10.1073/pnas.0505108102).

Simmonds, P.D., Eccles, D.M. and Gerty, S. (2005) Clinicopathological characteristics of young onset breast cancer: initial results from a prospective cohort study. Breast Cancer Research and Treatment, 94, (Supplement 1), p.S22. (doi:10.1007/s10549-005-1234-6).

Sinclair, P.B., Harrison, C.J., Jarosová, M. and Foroni, L. (2005) Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36). Haematologica, 90, (5), 602-611. (15921375).

Sooriakumaran, Prasanna, O'CONNOR, James and Underwood, Timothy J. (2005) Trainees advisory group for the international campaign to revitalise academic medicine: Have your say in shaping the future of medical education, research and clinical practice. International Journal of Surgery, 3, (1), 99-100. (doi:10.1016/j.ijsu.2005.03.007).

Steele, A.J., Al-Chalabi, A., Ferrante, K., Cudkowicz, M.E., Brown, R.H. and Garson, J. A. (2005) Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology, 64, (3), 454-458. (doi:10.1212/01.WNL.0000150899.76130.71 ).

Stevenson, Freda K. (2005) Turning genes into cancer vaccines. Discovery Medicine, 5, (25), 37-42.

Stevenson, Freda K. (2005) Update on cancer vaccines. Current Opinion in Oncology, 17, (6), 573-577.

Stirling, Diane, Evans, D. Gareth, Pichert, Gabriella, Shenton, Andrew, Kirk, Elaine N., Rimmer, Sylvia, Steel, C. Michael, Lawson, Sheila, Busby-Earle, R. M. Camille, Walker, Jane, Lalloo, Fiona I., Eccles, Diana M., Lucassen, Anneke M. and Porteous, Mary E. (2005) Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to The International Federation of Gynecology and Obstetrics System. Journal of Clinical Oncology, 23, (24), 5588-5596. (doi:10.1200/JCO.2005.05.097).

Strefford, Jon C., Stasevich, Irina, Lane, Tim M., Lu, Yong-Jie, Oliver, Tim and Young, Bryan D. (2005) A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma. Cancer Genetics and Cytogenetics, 159, (1), 1-9. (doi:10.1016/j.cancergencyto.2004.09.020).

Sumpter, K., Harper-Wynne, C., Cunningham, D., Rao, S., Tebbutt, N., Norman, A.R., Ward, C., Iveson, T., Nicolson, M., Hickish, T., Hill, M. and Oates, J. (2005) Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. British Journal of Cancer, 92, (11), 1976-1983. (doi:10.1038/sj.bjc.6602572).

Sébire, G., Tabarki, B., Saunders, D.E., Leroy, I., Liesner, R., Saint-Martin, C., Husson, B., Williams, A.N. and Kirkham, F.J. (2005) Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain, 128, (3), 477-489. (doi:10.1093/brain/awh412).

Thompson, Ella, Dragovic, Rebecca L., Stephenson, Sally-Anne, Eccles, Diana M., Campbell, Ian G. and Dobrovic, Alexander (2005) A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer. BMC Cancer, 5, (1) (doi:10.1186/1471-2407-5-43).

Tomlin, Jennifer L., Guinn, Barbara-Ann, Penn, Linda Z. and Berinstein, Neil L. (2005) Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalised human B-cell line GM607 but do not confer tumourigenicity. Leukemia and Lymphoma, 46, (4), 581-592. (doi:10.1080/10428190400019867).

Tommiska, J., Seal, S., Renwick, A., Barfoot, R., Baskcomb, L., Jayatilake, H., Bartkova, J., Tallila, J., Kaare, M., Tamminen, A., Heikkila, P., Evans, D.G., Eccles, D., Aittomaki, K., Blomqvist, C., Bartek, J., Stratton, M.R., Nevanlinna, H. and Rahman, N. (2005) Evaluation of RAD50 in familial breast cancer predisposition. International Journal of Cancer, 118, (11), 2911-2916. (doi:10.1002/ijc.21738).

Townsend, P., Packham, G., Barry, S., Chen-Scarabelli, C., Raddino, R., Knight, R., Latchman, D. and Scarabelli, T. M. (2005) Cytoplasmic/nuclear relocation of myocyte BAG-1 provides endogenous cardioprotection in the intact rat heart exposed to ischemia/reperfusion injury. Circulation, 112, (17), p.U1195.

Townsend, Paul A., Cragg, Mark S., Davidson, Sean M., McCormick, James, Barry, Sean, Lawrence, Kevin M., Knight, Richard A., Hubank, Michael, Chen, Phang-Lang, Latchman, David S. and Stephanou, Anastasis (2005) STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. Journal of Cell Science, 118, (8), 1629-1639. (doi:10.1242/jcs.01728).

Townsend, Paul A., Stephanou, Anastasis, Packham, Graham and Latchman, David S. (2005) BAG-1: a multi-functional pro-survival molecule. The International Journal of Biochemistry and Cell Biology, 37, (2), 251-259. (doi:10.1016/j.biocel.2004.03.016).

Turner, Claire L.S., Temple, Karen and Lucassen, Anneke (2005) Genetics. In, Peebles, Allison, Connett, Gary J., Maddison, Judi and Gavin, Joan (eds.) Cystic Fibrosis Care: a Practical Guide. London, GB, Churchill Livingstone, 25-36.

Underwood, T.J. and (ICRAM) International Campaign to Revitalise Academic Medicine (2005) The future of academic medicine - five scenarios to 2025, New York, USA, Milbank Memorial Fund, 50pp.

Vago, Richard, Marsden, Catherine J., Lord, J. Michael, Ippoliti, Rodolfo, Flavell, David J., Flavell, Sopsamorn U., Ceriotti, Aldo and Fabbrini, M. Serena (2005) Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells. The FEBS Journal, 272, (19), 4983-4995. (doi:10.1111/j.1742-4658.2005.04908.x).

Westwood, G., Little, P., Pickering, R.M., Temple, I.K., Latter, S.M. and Lucassen, A.M. (2005) Referrals to clinical genetics services: GPs' attitudes and practice. Journal of Medical Genetics, 42, pp.S27.

Wheatley, Keith, Brookes, Cassey L., Hills, Robert K., Goldstone, Anthony H., Milligan, Donald W., Prentice, Archie G., Moorman, Anthony V. and Burnett, Alan K. (2005) Prognostic factors in older AML patients receiving intensive and non-intensive therapy: analysis of the UK AML11 and AML14 trials. Blood ASH Meeting Abstracts, 106, (11), 199A-199A.

White, Helen E., Durston, Victoria J., Seller, Anneke, Fratter, Carl, Harvey, John F. and Cross, Nicholas C.P. (2005) Accurate detection and quantitation of heteroplasmic mitochondrial point mutations by pyrosequencing. Genetic Testing, 9, (3), 190-199. (doi:10.1089/gte.2005.9.190).

Williams, Anthony P., Bateman, Andrew R. and Khakoo, Salim I. (2005) Hanging in the balance: KIR and their role in disease. Molecular Interventions, 5, (4), 226-240. (doi:10.1124/mi.5.4.6).

Wilson, Charlotte, Yang, Jinshu, Strefford, Jon C., Summersgill, Brenda, Young, Bryan D., Shipley, Janet, Oliver, Tim and Lu, Yong-Jie (2005) Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines. Genes, Chromosomes and Cancer, 43, (2), 211-216. (doi:10.1002/gcc.20173).

Zhu, Delin, Qi, Chen Feng, Morse, Herbert C., Janz, Siegfried and Stevenson, Freda K. (2005) Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt-like" lymphomas from naive B cells. Blood, 105, (5), 2135-2137. (doi:10.1182/blood-2004-07-2573).

This list was generated on Wed Dec 17 02:29:35 2014 GMT.